Edition:
United States

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

24.71USD
29 Mar 2017
Change (% chg)

$0.01 (+0.04%)
Prev Close
$24.70
Open
$24.59
Day's High
$24.83
Day's Low
$24.42
Volume
1,382,147
Avg. Vol
2,047,824
52-wk High
$25.65
52-wk Low
$18.00

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health,... (more)

Overall

Beta: 1.10
Market Cap(Mil.): $33,827.29
Shares Outstanding(Mil.): 1,368.97
Dividend: --
Yield (%): --

Financials

  BSX.N Industry Sector
P/E (TTM): 98.01 48.23 30.15
EPS (TTM): 0.25 -- --
ROI: 2.30 6.87 13.05
ROE: 5.32 10.83 14.20

BRIEF-Boston Scientific CEO Michael Mahoney's FY 2016 total compensation was $12 mln vs $11.6 mln in FY 2015

* CEO Michael Mahoney's FY 2016 total compensation was $12.0 million versus $11.6 million in FY 2015 - sec filing Source text (http://bit.ly/2ny4bpM) Further company coverage:

Mar 28 2017

U.S. medtech shares gain as investors seek shelter from drug price debate

NEW YORK Investors are seeking shelter in shares of U.S. medical device and supply companies, encouraged by their solid growth prospects and wary that President Donald Trump's criticism of drug prices makes owning pharmaceutical and biotechnology stocks risky.

Mar 13 2017

U.S. medtech shares gain as investors seek shelter from drug price debate

NEW YORK, March 13 Investors are seeking shelter in shares of U.S. medical device and supply companies, encouraged by their solid growth prospects and wary that U.S. President Donald Trump's criticism of drug prices makes owning pharmaceutical and biotechnology stocks risky.

Mar 13 2017

BRIEF-German patent court issues initial decision

* District court in Germany ruled that Boston Scientific's lotus valve infringes one of co's patents for transcatheter aortic valves

Mar 09 2017

BRIEF-Boston Scientific receives favorable rulings in Edwards Lifesciences litigation

* Boston scientific receives favorable rulings in edwards lifesciences litigation

Mar 09 2017

BRIEF-Edwards Lifesciences says UK patent court issues decision on transcatheter heart valves

* Edwards Lifesciences Corp says company is not changing its financial guidance

Mar 03 2017

Boston Scientific recalls Lotus Valve heart devices

Boston Scientific Corp said on Thursday it was recalling its Lotus range of heart devices, citing reports of problems with the locking mechanism, sending its shares down as much as 7.4 percent.

Feb 23 2017

UPDATE 3-Boston Scientific recalls Lotus Valve heart devices

* Co's last chance to maintain brand equity, interest - Stifel

Feb 23 2017

Boston Scientific recalls all Lotus Valve heart devices

Feb 23 Boston Scientific Corp said on Thursday it was recalling its range of Lotus Valve heart devices, citing reports of problems with the locking mechanism.

Feb 23 2017

BRIEF-Boston Scientific says on Feb. 23 announced voluntary removal of all Lotus Valve devices - SEC filing

* Boston Scientific - on February 23 co announced voluntary removal of all Lotus Valve devices - SEC filing

Feb 23 2017

More From Around the Web

Competitors

Earnings vs. Estimates